VenatoRx Pharmaceuticals Inc.

VenatoRx Pharmaceuticals Inc.

VenatoRx Pharmaceuticals Inc.

VenatoRx Pharmaceuticals, a disease-focused pharmaceutical company, focuses onthe discovery and development of novel anti-infective agents.
Type
B2b
Raised
$51.4M
Follow us
Alexa global traffic share
Latest funding
$9,400,000
Grant - 2017
CARB-X
$42,000,000
Venture capital (Series B) - 2017
Foresite Capital Abingworth Versant Ventures
Team Size
1–10
Employees
$9,400,000 Grant
businesswire

VenatoRx Pharmaceuticals Receives $9.4 Million Award from CARB-X to Develop a New Class of Antibiotic to Combat Multi-Dr...